https://www.avient.com/sites/default/files/2025-05/AVNT Q1 2025 Webcast Slides_w_non-GAAP.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • disruptions or inefficiencies in our supply chain, logistics, or operations; • changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; • fluctuations in raw material prices, quality and supply, and in energy prices and supply; • demand for our products and services; • production outages or material costs associated with scheduled or unscheduled maintenance programs; • unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • information systems failures and cyberattacks; • our ability to service our indebtedness and restrictions on our current and future operations due to our indebtedness; • amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, tariffs, and any recessionary conditions; and • other factors described in our Annual Report on Form 10-K under Item 1A, “Risk Factors.”You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
https://www.avient.com/sites/default/files/2025-05/AVNT Q1 2025 webcast slides_v17.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • disruptions or inefficiencies in our supply chain, logistics, or operations; • changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; • fluctuations in raw material prices, quality and supply, and in energy prices and supply; • demand for our products and services; • production outages or material costs associated with scheduled or unscheduled maintenance programs; • unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • information systems failures and cyberattacks; • our ability to service our indebtedness and restrictions on our current and future operations due to our indebtedness; • amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, tariffs, and any recessionary conditions; and • other factors described in our Annual Report on Form 10-K under Item 1A, “Risk Factors.”You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
https://www.avient.com/sites/default/files/2023-10/Nonwoven Colorants and Additives Brochure_A4.pdf
Avient offers a comprehensive portfolio of colorants and additives for nonwovens in the form of concentrates.
https://www.avient.com/sites/default/files/2022-02/ColorMatrix Triple A Brochure.pdf
COLORMATRIX TRIPLE A™ Additive technology which reduces acetaldehyde levels in PET packaging TECHNICAL DESCRIPTION Acetaldehyde (AA) forms as a result of thermal degradation during PET melt-processing and can increase as temperature, pressure and shear in processing rises.
https://www.avient.com/sites/default/files/2020-09/cai-healthcare-application-bulletin.pdf
COLORANTS & ADDITIVES FOR HEALTHCARE Essential polymer solutions for critical healthcare applications WHEN MATERIAL EXPERTISE IS CRITICAL AESTHETIC APPEAL Regulatory compliant and approved masterbatch colors use custom polymer colorants to achieve any shade SPECIAL EFFECTS Enhance your brand and stand apart with pearlescent, metallic, iridescent, fluorescent or thermo-chromatic effects SOLID TO LIQUID SOLUTIONS Choose from a full range of available color solutions, from liquid color to solid product forms ANTIMICROBIALS Efficacy performance and regulatory requirements are met in a wide range of resins compatible with Withstand™ antimicrobial technology SURFACE ENERGY MODIFICATION Additive technologies such as low retention, hydrophobic, lubricious, light diffusion, or anti-stat provide desired surface manipulation Materials used for today’s medical devices, parts and pharmaceutical packaging contribute significantly to performance and, in turn, to a patient’s health and well-being.
https://www.avient.com/sites/default/files/2024-08/Avient Thermoplastic Composite Tapes Product Overview.pdf
Available in rolls of unidirectional tape as well as X-Ply™ 0°/90° and other multi-ply laminates, Polystrand materials can be post- formed and co-molded with mixed materials in thermoforming and injection molding processes to provide lightweight strength to a variety of part designs.
https://www.avient.com/sites/default/files/2021-06/fl.us-.datasheet-nomex-meta-aramid.pdf
Over the last several years, FIBER-LINE® and DuPont™ have formed a strong partnership based upon the synergies between both organizations
https://www.avient.com/sites/default/files/2021-06/fl.a4.datasheet-novoloid.pdf
The reaction occurs and fibers are formed and cured.
https://www.avient.com/sites/default/files/resources/Forward%2520Looking%2520Statements%2520and%2520Non%2520GAAP%2520Measures.pdf
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
https://www.avient.com/sites/default/files/2021-01/virtual-reality-application-bulletin.pdf
DEFENSE • Battlefield simulation • Flight & vehicle simulation • Medic training • Virtual bootcamp CO NSUMER E DU CATION • Video games • Live events • Video entertainment • Theatre • Virtual theme parks • Virtual museums & galleries • Virtual immersion • Global connectivity HEALTHCARE • Surgical simulation • Phobia treatment • Robotic surgery • Skills training • Diagnostics RETAIL & FASHION• Virtual stores • 3D human forms for design • 3D fashion portfolios REAL ESTATE EN GINEERING • 3D modeling tools • Design tools • Prototyping • Construction • Architectural design • Virtual tours 1.844.4AVIENT www.avient.com Copyright © 2020, Avient Corporation.